The development of multiple COVID-19 vaccines in record time is a major biomedical
achievement, but mechanistic immune correlates of vaccine protection remain to be …

Vaccine designers take first shots at COVID-19 | Science news careers commentary
Journals Science Science brought to you byGoogle Indexer Log in science science …

The identification of CD4+ T cell epitopes is instrumental for the design of subunit vaccines
for broad protection against coronaviruses. Here, we demonstrate in COVID-19–recovered …

Boosting immunity to COVID-19 vaccines | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …

The adaptive immune response is a major determinant of the clinical outcome after SARS-
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …

INTRODUCTION Mass vaccination against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) offers the most efficient public health intervention to control the COVID-19 …

INTRODUCTION The clinical manifestations of COVID-19 vary from asymptomatic infection
to respiratory failure. Severe disease courses are primarily associated with advanced age …

Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2 | Nature Immunology Skip
to main content Thank you for visiting nature.com. You are using a browser version with limited …

Many unknowns exist about human immune responses to the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2–reactive CD4+ T cells have …

The teams of researchers scrambling to develop a coronavirus disease 2019 (COVID-19)
vaccine clearly face some big challenges, both scientific and logistical. One of the most …